Active ingredientMaytansineCat. No. P-M015-001CAS 35846-53-8Family · Pharmaceutical analytical standards
Maytansine
An antitumour macrolide isolated in 1972 from the Ethiopian shrub Maytenus serrata: it binds tubulin and blocks microtubules, halting cell division. This family brings together the active ingredient and other impurities.
Did you know?Too toxic to be used on its own, it now travels aboard antibodies: its derivatives, the maytansinoids, are the payload of antibody-drug conjugates such as trastuzumab emtansine.
Go to the active ingredient →Active ingredientMaytansineCat. No. P-M015-001CAS 35846-53-8
ImpurityDM1-SmccCat. No. P-M015-002CAS 1228105-51-8
ImpurityDM4-SmeCat. No. P-M015-003CAS 796073-68-2
ImpurityMaytansinoid DM4Cat. No. P-M015-006CAS 796073-69-3
ImpurityMaytansine Impurity 1Cat. No. P-M015-008CAS 890654-03-2
ImpurityMaytansine Impurity 2Cat. No. P-M015-010CAS 138148-68-2
ImpurityMaytansine Impurity 3Cat. No. P-M015-012CAS 905449-90-3
ImpurityMertansineCat. No. P-M015-013CAS 139504-50-0
ImpuritySpdb-DM4Cat. No. P-M015-014CAS 1626359-62-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.